Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

News Daily News

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Todd Neale

July 24, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

CVD Hospitalization in Older Adults Higher in US Than in Denmark

Michael O'Riordan

February 07, 2025

News Daily News

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

L.A. McKeown

January 21, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

News Daily News

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Michael O'Riordan

December 04, 2024

News Daily News

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Todd Neale

November 28, 2024

News Opinion Editor's Corner

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Michael O'Riordan

July 31, 2024

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Autism and Cardiometabolic Disease Often Go Hand in Hand

Caitlin E. Cox

February 06, 2023

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

Yael L. Maxwell

August 12, 2022

News Daily News

CV Risk Factors, Disease Projected to Explode in Coming Decades

L.A. McKeown

August 01, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

Yael L. Maxwell

October 14, 2021

News Conference News ESC 2021

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Michael O'Riordan

September 03, 2021

Advertisement

AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review

Amylin Analogue Boosts Weight Loss When Added to GLP-1

CVD Hospitalization in Older Adults Higher in US Than in Denmark

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results

Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis

Olympic Hearts: Screening for CVD Among Team USA’s Athletes

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Autism and Cardiometabolic Disease Often Go Hand in Hand

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

CV Risk Factors, Disease Projected to Explode in Coming Decades

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD

New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content